Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial

Controlled Trial ◽

Stage Ii ◽

Survival Outcomes ◽

Phase 3 ◽

Faculty Opinions recommendation of Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964860.793469200 ◽

2013 ◽

Author(s):

Kellie Mathis

Keyword(s):

Colon Cancer ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Phase 3 ◽

A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial

European Journal of Cancer ◽

10.1016/j.ejca.2018.03.009 ◽

2018 ◽

Vol 96 ◽

pp. 54-63 ◽

Cited By ~ 24

Author(s):

Chu Matsuda ◽

Megumi Ishiguro ◽

Satoshi Teramukai ◽

Yoshiki Kajiwara ◽

Shoichi Fujii ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Chemotherapy ◽

Controlled Trial ◽

Stage Ii ◽

Stage Ii Colon Cancer ◽

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(12)70509-0 ◽

2012 ◽

Vol 13 (12) ◽

pp. 1225-1233 ◽

Cited By ~ 316

Author(s):

Aimery de Gramont ◽

Eric Van Cutsem ◽

Hans-Joachim Schmoll ◽

Josep Tabernero ◽

Stephen Clarke ◽

...

Keyword(s):

Colon Cancer ◽

Adjuvant Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

D2 Gastrectomy ◽

Faculty Opinions recommendation of Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718302523.793494710 ◽

2014 ◽

Author(s):

Anthony Harries

Keyword(s):

Clinical Outcomes ◽

Antiretroviral Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Delayed Initiation ◽

Randomised Controlled ◽

Hiv 1

Faculty Opinions recommendation of Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9952956.10680055 ◽

2011 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Controlled Trial ◽

Phase 3 ◽

Conventional Radiotherapy ◽

Intensity Modulated ◽

Parotid Sparing ◽

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

SSRN Electronic Journal ◽

10.2139/ssrn.3478102 ◽

2019 ◽

Author(s):

Chiara Cremolini ◽

Carlotta Antoniotti ◽

Daniele Rossini ◽

Sara Lonardi ◽

Fotios Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Early Interdisciplinary Palliative Care in Patients with Previously Untreated Metastatic Oesophagogastric Cancer: A Phase 3 Randomised Controlled Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3582831 ◽

2020 ◽

Author(s):

Zhihao Lu ◽

Yu Fang ◽

Chang Liu ◽

Xiaotian Zhang ◽

Xiaowei Xin ◽

...

Keyword(s):

Palliative Care ◽

Controlled Trial ◽

Phase 3 ◽

Randomised Controlled ◽

Oesophagogastric Cancer

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00027-9 ◽

2021 ◽

Author(s):

Angela Lamarca ◽

Daniel H Palmer ◽

Harpreet Singh Wasan ◽

Paul J Ross ◽

Yuk Ting Ma ◽

...

Keyword(s):

Biliary Tract Cancer ◽

Controlled Trial ◽

Symptom Control ◽

Second Line ◽

Open Label ◽

Phase 3 ◽

Tract Cancer ◽

Folfox Chemotherapy ◽